KCNE2
Overview[edit]
KCNE2 is a gene that encodes a protein known as MinK-related peptide 1 (MiRP1), which is a member of the KCNE family of voltage-gated potassium (K+) channel ancillary subunits. These subunits are crucial for the modulation of cardiac and other physiological processes by altering the properties of potassium channels.
Structure[edit]
The KCNE2 gene is located on chromosome 21 in humans. The protein product, MiRP1, is a small transmembrane protein that interacts with various potassium channel alpha subunits to modify their function. MiRP1 is characterized by a single transmembrane domain, an extracellular N-terminus, and a cytoplasmic C-terminus.
Function[edit]
MiRP1 modulates the function of several potassium channels, including the HERG (human ether-à-go-go-related gene) channel, which is critical for cardiac repolarization. By associating with HERG, MiRP1 alters the kinetics and voltage dependence of the channel, impacting the cardiac action potential duration and, consequently, heart rhythm.
Clinical Significance[edit]
Mutations in the KCNE2 gene have been associated with various cardiac arrhythmias, including Long QT syndrome and ventricular fibrillation. These conditions can lead to syncope, seizures, or sudden cardiac death. The role of KCNE2 in these pathologies underscores the importance of proper potassium channel function in maintaining cardiac electrical stability.
Interactions[edit]
KCNE2 interacts with several potassium channel alpha subunits, including HERG, KCNQ1, and others. These interactions are essential for the proper functioning of the channels, influencing their gating properties and response to physiological stimuli.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which KCNE2 modulates potassium channel function and its role in cardiac and other physiological processes. Studies also aim to elucidate the impact of specific KCNE2 mutations on channel function and disease.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian